Healthcare provider profile · identity verified

Austin Moody, M.D.

Family Practice · JACKSONVILLE, FL · NPI 1881004299

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	334	68
Levothyroxine Sodium	Levothyroxine Sodium	195	44
Amlodipine Besylate	Amlodipine Besylate	154	40
Fluticasone Propionate	Fluticasone Propionate	151	29
Pantoprazole Sodium	Pantoprazole Sodium	139	31
Albuterol Sulfate Hfa	Albuterol Sulfate	137	25
Metformin Hcl	Metformin Hcl	117	19
Losartan Potassium	Losartan Potassium	108	30
Omeprazole	Omeprazole	97	19
Westab Plus	Pnv,calcium 72/Iron/Folic Acid	93	suppressed
Gabapentin	Gabapentin	91	30
Metoprolol Succinate	Metoprolol Succinate	80	20
Furosemide	Furosemide	79	29
Carvedilol	Carvedilol	77	15
Eliquis	Apixaban	75	14
Famotidine	Famotidine	75	12
Lisinopril	Lisinopril	74	20
Tamsulosin Hcl	Tamsulosin Hcl	73	12
Hydrochlorothiazide	Hydrochlorothiazide	67	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	18
Meloxicam	Meloxicam	58	suppressed
Potassium Chloride	Potassium Chloride	56	15
Jardiance	Empagliflozin	54	12
Rosuvastatin Calcium	Rosuvastatin Calcium	54	11
Metoprolol Tartrate	Metoprolol Tartrate	53	16
Simvastatin	Simvastatin	51	suppressed
Incruse Ellipta	Umeclidinium Bromide	50	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Trazodone Hcl	Trazodone Hcl	45	19
Mirtazapine	Mirtazapine	38	suppressed
Ketoconazole	Ketoconazole	37	14
Atenolol	Atenolol	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	12
Nifedipine Er	Nifedipine	35	suppressed
Breo Ellipta	Fluticasone/Vilanterol	34	suppressed
Allopurinol	Allopurinol	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Spironolactone	Spironolactone	33	11
Januvia	Sitagliptin Phosphate	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Azithromycin	Azithromycin	31	26
Ibuprofen	Ibuprofen	31	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Finasteride	Finasteride	30	suppressed
Prednisone	Prednisone	30	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Divalproex Sodium	Divalproex Sodium	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	17
Escitalopram Oxalate	Escitalopram Oxalate	26	17
Fenofibrate	Fenofibrate,micronized	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Ozempic	Semaglutide	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Donepezil Hcl	Donepezil Hcl	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Baclofen	Baclofen	21	suppressed
Metformin Hcl Er	Metformin Hcl	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Enulose	Lactulose	19	suppressed
Nystatin	Nystatin	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Fluconazole	Fluconazole	17	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ramipril	Ramipril	14	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Levocarnitine	Levocarnitine	13	suppressed
Temazepam	Temazepam	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Levofloxacin	Levofloxacin	12	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Cefdinir	Cefdinir	11	suppressed
Ibu	Ibuprofen	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error